Results 11 to 20 of about 851,197 (206)

Nanotechnology in pulmonary medicine. [PDF]

open access: yesCurr Opin Pharmacol, 2021
Nanotechnology in medicine-nanomedicine-is extensively employed to diagnose, treat, and prevent pulmonary diseases. Over the last few years, this brave new world has made remarkable progress, offering opportunities to address historical clinical challenges in pulmonary diseases including multidrug resistance, adverse side effects of conventional ...
Doroudian M   +5 more
europepmc   +5 more sources

Characteristics of Pulmonary Critical Care Medicine and Pulmonary Medicine Applicants and Fellowships. [PDF]

open access: yesATS Sch, 2020
Background: Little is known about historical and recent application trends for pulmonary critical care medicine (PCCM) or pulmonary medicine (PM) fellowship programs. Describing trends in and characteristics of PCCM and PM applications, applicants, and fellowship programs can help program directors and medical educators understand trainees' interest in
Richards JB, Spiegel MC, Wilcox SR.
europepmc   +4 more sources

Pulmonary nuclear medicine [PDF]

open access: yesEuropean Journal of Nuclear Medicine, 1992
This article reviews the contribution made by nuclear imaging to the assessment, diagnosis and monitoring of patients with respiratory disease. It focuses on several specific areas including the diagnosis of pulmonary embolism, the investigation of intrapulmonary infection and neoplasm and the role of positron emission tomography (PET) scanning.
Miller, R F, O'Doherty, M J
openaire   +3 more sources

The initial experience of COVID-19 vaccination from a tertiary care centre of India

open access: yesMonaldi Archives for Chest Disease, 2021
To the Editor Drugs Controller General of India (DCGI) has approved the Bharat biotech vaccine against COVID-19, which is a locally manufactured inactivated vaccine named ''COVAXIN'' in collaboration with the Indian council of medical research (ICMR ...
RK Srivastava   +2 more
doaj   +1 more source

Baixa prevalência das manifestações extra-articulares renais, cardíacas, pulmonares e neurológicas nas espondiloartrites: análise do Registro Brasileiro de Espondiloartrites Low prevalence of renal, cardiac, pulmonary, and neurological extra-articular clinical manifestations in spondyloarthritis: analysis of the Brazilian Registry of Spondyloarthritis

open access: yesRevista Brasileira de Reumatologia, 2012
OBJETIVO: Descrever as manifestações extra-articulares (cardíacas, renais, pulmonares e neurológicas) geralmente não relacionadas às espondiloartrites (EpA) em uma grande coorte de pacientes brasileiros.
Carlos Ewerton Maia Rodrigues   +32 more
doaj   +1 more source

Pulmonary Medicine [PDF]

open access: yesApproach to Internal MedicineA Resource Book for Clinical Practice, 2010
• oropharynx—enlarged tonsils, retropharyngeal abscess, obesity, post-nasal drip • larynx—laryngeal edema, laryngostenosis, laryngocele, epiglottitis, anaphylaxis, severe laryngopharyngeal reflux, and laryngospasm • vocal cords—vocal cord dysfunction, paralysis, hematoma, tumor, cricoarytenoid ...
Hui D.
europepmc   +2 more sources

Effectiveness of a multidisciplinary pulmonary rehabilitation program at Ewha Womans University Mokdong Hospital, Korea [PDF]

open access: yesThe Ewha Medical Journal
Objectives: This study aimed to evaluate the effectiveness of a multidisciplinary pulmonary rehabilitation program at Ewha Womans University Mokdong Hospital, Korea that was designed to augment respiratory function, promote patient recovery, and improve ...
Soo Jeong Han, Jee Hyun Suh
doaj   +1 more source

An analysis of potential costs of adverse events based on Drug Programs in Poland. Pulmonology focus

open access: yesCurrent Issues in Pharmacy and Medical Sciences, 2014
The project was performed within the Polish Society for Pharmacoeconomics (PTFE). The objective was to estimate the potential costs of treatment of side effects, which theoretically may occur as a result of treatment of selected diseases. We analyzed the
Szkultecka-Debek Monika   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy